LentiCRISPRv2bleo-Necl-5
(Plasmid
#170294)
-
PurposeA knock-out vector for the mouse Necl-5
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 170294 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneLentiCRISPRv2puro
-
Backbone manufacturerhttps://www.addgene.org/52961/
-
Modifications to backboneA puromycin-resistant gene in lentiCRISPR v2 vector was replaced with a bleomycin-resistant gene.
-
Vector typeLentiviral, CRISPR
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameA gRNA targeting the mouse Necl-5 gene.
-
gRNA/shRNA sequenceNecl-5
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BsmBI (unknown if destroyed)
- 3′ cloning site BsmBI (unknown if destroyed)
- 5′ sequencing primer hU6-F (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LentiCRISPRv2bleo-Necl-5 was a gift from Michiyuki Matsuda (Addgene plasmid # 170294 ; http://n2t.net/addgene:170294 ; RRID:Addgene_170294) -
For your References section:
Functional visualization of NK Cell-mediated killing of metastatic single tumor cells. Ichise H, Tsukamoto S, Hirashima T, Konishi Y, Oki C, Tsukiji S, Iwano S, Miyawaki A, Sumiyama K, Terai K, Matsuda M. Elife. 2022 Feb 3;11. pii: 76269. doi: 10.7554/eLife.76269. 10.7554/eLife.76269 PubMed 35113018